Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy Subjects

NCT03165097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: ACT-709478
DRUG: Placebo
DRUG: Midazolam
DRUG: ACT-709478 combined with midazolam

Sponsor

Idorsia Pharmaceuticals Ltd.